Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Buckley

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|April 17, 2003
Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychoticPeter F Buckley
The Journal of Nervous and Mental Disease|October 4, 2011
Bromization: the truths we know about the psychopharmacology of schizophreniaPeter F Buckley
Clinical Schizophrenia & Related Psychoses|March 7, 2019
Clinical NewsPeter F Buckley
The Journal of Clinical Psychiatry|June 27, 2008
Factors that influence treatment success in schizophreniaPeter F Buckley
Expert Opinion on Pharmacotherapy|October 4, 2005
Olanzapine: a critical review of recent literaturePeter F Buckley
Current Medical Research and Opinion|September 24, 2004
Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trialsPeter F Buckley
CNS Spectrums|March 28, 2008
Update on the treatment and management of schizophrenia and bipolar disorderPeter F Buckley
Clinical Schizophrenia & Related Psychoses|January 22, 2015
Drug development updatePeter F Buckley
The Journal of Clinical Psychiatry|July 31, 2007
Receptor-binding profiles of antipsychotics: clinical strategies when switching between agentsPeter F Buckley
Clinical Schizophrenia & Related Psychoses|July 26, 2017
Clinical NewsPeter F Buckley
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Drugs of Today (Barcelona, Spain : 1998)|April 17, 2003
Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychoticPeter F Buckley
The Journal of Nervous and Mental Disease|October 4, 2011
Bromization: the truths we know about the psychopharmacology of schizophreniaPeter F Buckley
Clinical Schizophrenia & Related Psychoses|March 7, 2019
Clinical NewsPeter F Buckley
The Journal of Clinical Psychiatry|June 27, 2008
Factors that influence treatment success in schizophreniaPeter F Buckley
Expert Opinion on Pharmacotherapy|October 4, 2005
Olanzapine: a critical review of recent literaturePeter F Buckley
Current Medical Research and Opinion|September 24, 2004
Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trialsPeter F Buckley
CNS Spectrums|March 28, 2008
Update on the treatment and management of schizophrenia and bipolar disorderPeter F Buckley
Clinical Schizophrenia & Related Psychoses|January 22, 2015
Drug development updatePeter F Buckley
The Journal of Clinical Psychiatry|July 31, 2007
Receptor-binding profiles of antipsychotics: clinical strategies when switching between agentsPeter F Buckley
Clinical Schizophrenia & Related Psychoses|July 26, 2017
Clinical NewsPeter F Buckley
Pageof 18